Roquefort Therapeutics plc (LON:ROQ – Get Free Report) insider Dr Darrin Disley bought 269,935 shares of Roquefort Therapeutics stock in a transaction that occurred on Tuesday, August 1st. The shares were acquired at an average cost of GBX 7 ($0.09) per share, with a total value of £18,895.45 ($24,259.15). Roquefort Therapeutics Price Performance Shares of […]
Investegate |Roquefort Theraptcs Announcements | Roquefort Theraptcs : Director/PDMR Shareholding investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Roquefort Therapeutics completes Oncogeni deal for GBP5 5 million lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.
Mogrify looks to transform cell therapy development biopharma-reporter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharma-reporter.com Daily Mail and Mail on Sunday newspapers.